231 related articles for article (PubMed ID: 22457815)
1. Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis.
Zhang LQ; Wang J; Jiang F; Xu L; Liu FY; Yin R
PLoS One; 2012; 7(3):e34100. PubMed ID: 22457815
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma.
Liu JL; Zhang XJ; Zhang Z; Zhang AH; Wang W; Dong JH
PLoS One; 2013; 8(12):e83350. PubMed ID: 24386184
[TBL] [Abstract][Full Text] [Related]
4. Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies.
Huang LN; Wang DS; Chen YQ; Zhao CL; Gong BL; Jiang AB; Jia W; Hu FD
Mol Biol Rep; 2013 Feb; 40(2):917-24. PubMed ID: 23065255
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
7. Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hu YM; Li J; Yu LC; Shi SB; Du YJ; Wu JN; Shi WL
Pathol Oncol Res; 2015 Apr; 21(2):257-65. PubMed ID: 24980156
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of survivin in patients with non-Hodgkin's lymphoma: a meta-analysis.
He C; Liu Z; Ji J; Zhu H
Int J Clin Exp Med; 2015; 8(4):5847-54. PubMed ID: 26131175
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
10. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
Fan J; Wang L; Jiang GN; He WX; Ding JA
Lung Cancer; 2008 Jul; 61(1):91-6. PubMed ID: 18192073
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of survivin expression in breast cancer patients: a meta-analysis.
Song J; Su H; Zhou YY; Guo LL
Tumour Biol; 2013 Aug; 34(4):2053-62. PubMed ID: 23690235
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.
Lv S; Turlova E; Zhao S; Kang H; Han M; Sun HS
Tumour Biol; 2014 Feb; 35(2):1565-74. PubMed ID: 24101190
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
[TBL] [Abstract][Full Text] [Related]
14. Nuclear survivin expression is associated with a poor prognosis in Caucasian non-small cell lung cancer patients.
Xie YL; An L; Jiang H; Wang J
Clin Chim Acta; 2012 Dec; 414():41-3. PubMed ID: 22981350
[TBL] [Abstract][Full Text] [Related]
15. Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.
Duan L; Hu X; Jin Y; Liu R; You Q
BMC Cancer; 2016 Apr; 16():276. PubMed ID: 27090386
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
Yang T; Hao L; Yang X; Luo C; Wang G; Lin Cai C; Qi S; Li Z
BMJ Open; 2021 Sep; 11(9):e049123. PubMed ID: 34475167
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Zhu L; Yu H; Liu SY; Xiao XS; Dong WH; Chen YN; Xu W; Zhu T
PLoS One; 2015; 10(4):e0124230. PubMed ID: 25905787
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.
Meng D; Yuan M; Li X; Chen L; Yang J; Zhao X; Ma W; Xin J
Lung Cancer; 2013 Jul; 81(1):1-10. PubMed ID: 23608713
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of survivin levels in circulation and tissue samples of lung cancer patients.
Kapellos G; Polonifi K; Farmakis D; Spartalis E; Tomos P; Aessopos A; Polizos A; Mantzourani M
Anticancer Res; 2013 Aug; 33(8):3475-80. PubMed ID: 23898122
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
Zhou LQ; Hu Y; Xiao HJ
BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
